Piedmont Lithium Inc. (PLLTL)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 31.38 Million | 19.73 Million | 10.18 Million | 9.5 Million | 1.8 Million | 615.68 Thousand |
| Selling, General and Administrative Expenses | 29.44 Million | 8.86 Million | 3.07 Million | 2.31 Million | 1.33 Million | 214.65 Thousand |
| Research and Development Expenses | - | - | - | 1.2 Million | - | - |
| Other Expenses | 1.93 Million | 10.87 Million | 7.11 Million | -577.37 Thousand | 469.9 Thousand | 401.03 Thousand |
| Cost and Expenses | 31.38 Million | 19.73 Million | 10.18 Million | 9.5 Million | 2.72 Million | 398.21 Thousand |
| Operating Income | -39.74 Million | -19.73 Million | -10.41 Million | -10.19 Million | -2.68 Million | -286.74 Thousand |
| Interest Expense | 115.02 Thousand | 193.26 Thousand | 157.27 Thousand | - | - | - |
| Income Tax Expense | 3.13 Million | 257.89 Thousand | -596.55 Thousand | -237.82 Thousand | - | - |
| Earnings before Tax | -9.83 Million | -19.92 Million | -9.82 Million | -9.89 Million | -2.68 Million | -286.74 Thousand |
| Net Income | -12.97 Million | -19.99 Million | -9.82 Million | -9.89 Million | -2.68 Million | -286.74 Thousand |
| Earnings Per Share Basic | -0.74 | -1.48 | -0.71 | -0.02 | -0.01 | -0.00 |
| Earnings Per Share Diluted | -0.74 | -1.48 | -0.71 | -0.02 | -0.01 | -0.00 |
| Weighted Average Shares Outstanding | 17.51 Million | 13.55 Million | 8.27 Million | 5.2 Million | 4.09 Million | 3.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.51 Million | 13.55 Million | 8.27 Million | 5.2 Million | 4.09 Million | 3.97 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -9.55 Million | -19.79 Million | -10.41 Million | -9.55 Million | -2.68 Million | -279.29 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 47.12 Million | - | - | - | - | - |
| Cost of Revenue | 23.36 Million | - | - | - | - | - |
| Gross Profit | 23.76 Million | - | - | - | - | - |
| Operating Expenses | 11.65 Million | 12.42 Million | 9.37 Million | 31.38 Million | 9.7 Million | 7.59 Million |
| Selling, General and Administrative Expenses | 11.18 Million | 11.98 Million | 8.62 Million | - | 9.24 Million | 7.16 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 471 Thousand | 440.19 Billion | 756.77 Thousand | 1.93 Million | 454.6 Thousand | 434.17 Thousand |
| Cost and Expenses | 35.01 Million | 12.42 Million | 9.37 Million | 31.38 Million | 9.7 Million | 7.59 Million |
| Operating Income | 15.96 Million | -15.1 Million | -12.12 Million | -39.74 Million | -11.5 Million | 20.14 Million |
| Interest Expense | 8000.00 | 11.16 Thousand | 14.51 Thousand | 115.02 Thousand | 17.77 Thousand | 20.64 Thousand |
| Income Tax Expense | 2.02 Million | 648.81 Thousand | 493.34 Thousand | 3.13 Million | -282.95 Thousand | 3.42 Million |
| Earnings before Tax | 24.91 Million | -9.99 Million | -8.14 Million | -9.83 Million | -11.18 Million | 20.08 Million |
| Net Income | 22.89 Million | -10.63 Million | -8.63 Million | -12.97 Million | -10.9 Million | 16.66 Million |
| Earnings Per Share Basic | 1.19 | -0.55 | -0.47 | - | -0.62 | 0.93 |
| Earnings Per Share Diluted | 1.19 | -0.55 | -0.47 | - | -0.62 | 0.92 |
| Weighted Average Shares Outstanding | 19.2 Million | 19.18 Million | 18.52 Million | 17.51 Million | 17.51 Million | 17.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.23 Million | 19.18 Million | 18.52 Million | 17.51 Million | 17.51 Million | 18.08 Million |
| Gross Margin | 0.50 | - | - | - | - | - |
| EBIT Margin | 0.53 | - | - | - | - | - |
| Profit Margin | 0.49 | - | - | - | - | - |
| EBITDA | 25.01 Million | -9.9 Million | -11.31 Million | - | -11.09 Million | 20.16 Million |
| Earnings Before Tax Margin | 0.34 | - | - | - | - | - |
SEMAC
JAGSNPHARM
6262
BEIJF
300042
INNOCORP